Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The utility of BRAFV600E mutation-specific antibody for colon cancers with microsatellite instability.

Applied immunohistochemistry & molecular morphology : AIMM - 1 Jan 2000

Nolan Stephanie, Arnason Thomas, Drucker Arik, Huang Weei-Yuarn

Abstract excerpt

This study's objective was to assess the performance of immunohistochemical staining with the BRAF mutation-specific antibody (clone VE1) in tissue from colon cancers, including those with a high degree of microsatellite instability (MSI-H). VE1 was applied to tissue microarrays of 152 colon cancers with known MSI status. Results of immunohistochemical analyses were scored as negative, positive, or equivocal. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epitopes

Share to Immunohistochemistry

Share to Mutation

Share to Polymerase Chain Reaction

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 24805134
DOI: 10.1097/PAI.0000000000000026

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The utility of BRAFV600E mutation-specific antibody for colon cancers with microsatellite instability.PMID 24805134Read ↗

Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.Semantic proximity Read ↗

BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancerSemantic proximity Read ↗

Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.Semantic proximity Read ↗

Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms.Semantic proximity Read ↗

Diagnostic value of immunohistochemistry for the detection of the BRAF V600E mutation in colorectal carcinoma.Semantic proximity Read ↗

VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.Semantic proximity Read ↗

Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.Semantic proximity Read ↗

Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.Semantic proximity Read ↗

Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.Semantic proximity Read ↗

Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.Semantic proximity Read ↗

Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomasSemantic proximity Read ↗

BRAF V600E mutation-specific antibody: A review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.